journal
Journals European Journal of Clinical P...

European Journal of Clinical Pharmacology

https://read.qxmd.com/read/36917243/increased-major-bleeding-incidence-in-atrial-fibrillation-patients-with-apixaban-a-review-of-japanese-post-marketing-surveillance-studies-of-direct-oral-anticoagulants
#1
REVIEW
Akinori Sairaku, Yukiko Nakano
Large-scaled post-marketing surveillance studies (PMSSs) of 4 direct oral anticoagulants (DOACs) for stroke prevention in non-valvular atrial fibrillation (AF) were conducted since 2011 in Japan, and the results of the last one have recently been published. Each reported a more than acceptable ischemic stroke prevention. The major bleeding rates were also acceptably low and comparable to each other in the PMSSs of dabigatran (J-dabigatran), rivaroxaban (XAPASS), and edoxaban (ETNA-AF-Japan). However, the incidence in PMSS of apixaban (STANDARD) was more than double the others...
March 14, 2023: European Journal of Clinical Pharmacology
https://read.qxmd.com/read/36912957/tacrolimus-improved-the-pregnancy-outcomes-of-patients-with-refractory-recurrent-spontaneous-abortion-and-immune-bias-disorders-a-randomized-controlled-trial
#2
JOURNAL ARTICLE
Juan Liu, Meiqin Li, Jinhua Fu, Guiling Yuan, Ning Li, Yinghui Fu, Long Zhao
OBJECTIVE: To investigate the effect of tacrolimus treatment on refractory recurrent spontaneous abortion (RSA) patients with elevated serum IL-33/ST2 levels. METHODS: This study was a randomized controlled trial (RCT) of refractory RSA patients with elevated peripheral blood IL-33/ST2 levels or an elevated Th1/Th2 cell ratio. A total of 149 women were enrolled, each of whom had had at least 3 serial miscarriages and was confirmed to have elevated peripheral blood IL-33/ST2 levels or an elevated Th1/Th2 cell ratio...
March 13, 2023: European Journal of Clinical Pharmacology
https://read.qxmd.com/read/36905428/evaluation-of-global-trigger-tool-as-a-medication-safety-tool-for-adverse-drug-event-detection-a-cross-sectional-study-in-a-tertiary-hospital
#3
JOURNAL ARTICLE
Ville Valkonen, Kaisa Haatainen, Susanna Saano, Miia Tiihonen
The objective of this study is to describe and analyze adverse drug events (ADE) identified using the Global trigger tool (GTT) in a Finnish tertiary hospital during a 5-year period and also to evaluate whether the medication module of the GTT is a useful tool for ADE detection and management or if modification of the medication module is needed. A cross-sectional study of retrospective record review in a 450-bed tertiary hospital in Finland. Ten randomly selected patients from electronic medical records were reviewed bimonthly from 2017 to 2021...
March 11, 2023: European Journal of Clinical Pharmacology
https://read.qxmd.com/read/36892631/safety-of-pitolisant-a-study-in-the-who-international-pharmacovigilance-database
#4
JOURNAL ARTICLE
Jean-Louis Montastruc
No abstract text is available yet for this article.
March 9, 2023: European Journal of Clinical Pharmacology
https://read.qxmd.com/read/36884061/waivers-of-informed-consent-in-research-with-competent-participants-and-the-declaration-of-helsinki
#5
REVIEW
Rafael Dal-Ré
No abstract text is available yet for this article.
March 8, 2023: European Journal of Clinical Pharmacology
https://read.qxmd.com/read/36872367/effect-of-digoxin-on-all-cause-and-cardiovascular-mortality-in-patients-with-atrial-fibrillation-with-and-without-heart-failure-an-umbrella-review-of-systematic-reviews-and-12-meta-analyses
#6
REVIEW
Gianluca Gazzaniga, Danilo Menichelli, Francesco Scaglione, Alessio Farcomeni, Arianna Pani, Daniele Pastori
PURPOSE: To perform a systematic umbrella review with meta-analysis to evaluate the certainty of evidence on mortality risk associated with digoxin use in patients with atrial fibrillation (AF) with or without heart failure (HF). METHODS: We systematically searched MEDLINE, Embase, and Web of Science databases from inception to 19 October 2021. We included systematic reviews and meta-analyses of observational studies investigating digoxin effects on mortality of adult patients with AF and/or HF...
March 6, 2023: European Journal of Clinical Pharmacology
https://read.qxmd.com/read/36853386/evidence-based-medication-adherence-among-seniors-in-the-first-year-after-heart-failure-hospitalisation-and-subsequent-long-term-outcomes-a-restricted-cubic-spline-analysis-of-adherence-outcome-relationships
#7
JOURNAL ARTICLE
Xiwen Qin, Joseph Hung, Matthew W Knuiman, Tom G Briffa, Tiew-Hwa Katherine Teng, Frank M Sanfilippo
PURPOSE: Non-adherence to heart failure (HF) medications is associated with poor outcomes. We used restricted cubic splines (RCS) to assess the continuous relationship between adherence to renin-angiotensin system inhibitors (RASI) and β-blockers and long-term outcomes in senior HF patients. METHODS: We identified a population-based cohort of 4234 patients, aged 65-84 years, 56% male, who were hospitalised for HF in Western Australia between 2003 and 2008 and survived to 1-year post-discharge (landmark date)...
February 28, 2023: European Journal of Clinical Pharmacology
https://read.qxmd.com/read/36823470/utilization-of-triple-antithrombotic-therapy-in-patients-with-atrial-fibrillation-undergoing-percutaneous-coronary-intervention
#8
JOURNAL ARTICLE
Hye-Jeong Choi, Yonghyuk Lee, Susin Park, Nam Kyung Je
BACKGROUND: Triple antithrombotic therapy (TAT), a combination of an oral anticoagulant and dual antiplatelet therapy (DAPT), is a key treatment for prevention of ischemic events in patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI). However, TAT is not extensively used because of the risk of bleeding. This study aimed to determine the utilization and influencing factors of TAT using real-world data in the non-vitamin K antagonist oral anticoagulants (NOACs) era...
February 24, 2023: European Journal of Clinical Pharmacology
https://read.qxmd.com/read/36811671/does-formative-assessment-help-students-to-acquire-prescribing-skills
#9
JOURNAL ARTICLE
L S Kalfsvel, L E J Peeters, K Hoek, C Bethlehem, I H van der Sijs, P H M van der Kuy, W W van den Broek, J Versmissen, F van Rosse
PURPOSE: Formative assessments can help motivate students and ease students' learning through feedback. There is a pressing need for improvement of clinical pharmacotherapy (CPT) education since junior doctors make many prescribing errors. The aim of this study was to determine whether a formative assessment with personalized narrative feedback helps medical students to increase their prescribing skills. METHODS: This retrospective cohort study was conducted among masters' medical students at Erasmus Medical Centre, The Netherlands...
February 22, 2023: European Journal of Clinical Pharmacology
https://read.qxmd.com/read/36806970/development-and-application-of-adverse-drug-reactions-reports-quality-algorithm-aqua-12-score-a-single-centre-quality-improvement-initiative
#10
JOURNAL ARTICLE
Ar Kar Aung, Celia M Zubrinich, Michelle S Y Goh, Benjamin Snyder, Mei Jie Tang, Cindy Y L Khu, Jennifer I Lee, Linda V Graudins
PURPOSE: To develop a reliable assessment tool to monitor the quality of adverse drug reaction (ADR) reports and evaluate its performance within a quaternary hospital setting. METHODS: Adverse drug reactions report QUality Algorithm (AQUA-12) was developed by a multidisciplinary team with the expertise in the management of ADRs. The design was based on data elements required to establish medication causality. Inter-rater reliability of AQUA-12 was evaluated over three rounds in two phases: development and prospective evaluation phases, by independent assessors both internal and external to the institutional ADR review processes...
February 20, 2023: European Journal of Clinical Pharmacology
https://read.qxmd.com/read/36806969/prediction-of-cyp2d6-poor-metabolizers-by-measurements-of-solanidine-and-metabolites-a-study-in-839-patients-with-known-cyp2d6-genotype
#11
REVIEW
Birgit M Wollmann, Elisabet Størset, Marianne Kristiansen Kringen, Espen Molden, Robert L Smith
PURPOSE: Poor metabolizers (PMs) of the highly polymorphic enzyme CYP2D6 are usually at high risk of adverse effects during standard recommended dosing of CYP2D6-metabolized drugs. We studied if the metabolism of solanidine, a dietary compound found in potatoes, could serve as a biomarker predicting the CYP2D6 PM phenotype for precision dosing. METHODS: The study included 839 CYP2D6-genotyped patients who were randomized by a 4:1 ratio into test or validation cohorts...
February 20, 2023: European Journal of Clinical Pharmacology
https://read.qxmd.com/read/36795127/the-efficacy-and-safety-of-direct-oral-anticoagulants-versus-vitamin-k-antagonists-in-patients-with-left-sided-bioprosthetic-heart-valves-and-atrial-fibrillation-a-systematic-review-and-meta-analysis
#12
REVIEW
Dong Li, Peng Chang, Hongliang Zhang, Feng Bai, Qiang Wu
BACKGROUND: The efficacy and safety of direct oral anticoagulants (DOACs) versus vitamin K antagonists (VKAs) for the treatment of patients with left-sided bioprosthetic heart valves (BHV) and atrial fibrillation (AF) remain controversial. This study aims to perform a meta-analysis to evaluate the efficacy and safety of DOACs versus VKAs in this region. METHODS: We retrieved all relevant randomized controlled studies and observational cohort studies, which critically assessed the efficacy and safety of DOACs versus VKAs among patients with left-sided BHV and AF in databases of PubMed, Cochrane, ISI Web of Sciences, and Embase...
February 16, 2023: European Journal of Clinical Pharmacology
https://read.qxmd.com/read/36773042/sequencing-strategies-with-ramucirumab-and-docetaxel-following-prior-treatments-for-advanced-non-small-cell-lung-cancer-a-multicenter-retrospective-cohort-study
#13
JOURNAL ARTICLE
Satoshi Tanizaki, Kinnosuke Matsumoto, Akihiro Tamiya, Yoshihiko Taniguchi, Yoshinobu Matsuda, Junji Uchida, Kiyonobu Ueno, Hayato Kawachi, Motohiro Tamiya, Takafumi Yanase, Hidekazu Suzuki, Kyoichi Okishio
OBJECTIVES: Ramucirumab (RAM) and docetaxel (DOC) are commonly used after first-line therapy for advanced non-small cell lung cancer (NSCLC). Therefore, we aimed to elucidate sequencing strategies of RAM and DOC following prior treatments, including immune checkpoint inhibitor (ICI), cytotoxic agent (CTx) alone, bevacizumab (BEV), and tyrosine kinase inhibitor (TKI). METHODS: We recruited patients with NSCLC who received RAM and DOC and compared the groups with and without prior ICI, CTx alone, BEV, and TKI, respectively...
February 11, 2023: European Journal of Clinical Pharmacology
https://read.qxmd.com/read/36763111/influence-of-metformin-on-hyperandrogenism-in-women-with-polycystic-ovary-syndrome-a-systematic-review-and-meta-analysis-of-randomized-clinical-trials
#14
REVIEW
Adriana F S Fontes, Fernando M Reis, Ana Lúcia Cândido, Karina B Gomes, Jéssica A G Tosatti
PURPOSE: To summarize the effects of metformin treatment on markers of hyperandrogenism in patients diagnosed with polycystic ovary syndrome (PCOS). METHODS: A systematic review, with meta-analysis, of randomized placebo-controlled clinical trials that evaluated the effects of metformin treatment in adult patients with PCOS on the levels of hyperandrogenism markers was conducted. The literature search, data extraction, risk of bias, and the assessment of certainty of evidence were performed independently by two reviewers using a structured form...
February 10, 2023: European Journal of Clinical Pharmacology
https://read.qxmd.com/read/36757428/dihydropyrimidine-dehydrogenase-phenotype-in-peripheral-blood-mononuclear-cells-is-related-to-adverse-events-of-fluoropyrimidine-therapy
#15
JOURNAL ARTICLE
K R Doornhof, P D van der Linden, G M Boeke, A E C A B Willemsen, A Daskapan
PURPOSE: The primary objective of this study was to determine if dihydropyrimidine dehydrogenase (DPD) activity measured in peripheral blood mononuclear cells (PBMCs) is related to adverse events during fluoropyrimidine therapy. METHODS: A retrospective cohort study was conducted. The study population included 481 patients who received fluoropyrimidine treatment and for whom relevant patient characteristics were known and adverse events were noted in the electronic health records...
February 9, 2023: European Journal of Clinical Pharmacology
https://read.qxmd.com/read/36749353/educational-value-of-international-and-intercultural-differences-in-prescribing-the-international-and-interprofessional-student-run-clinic-project
#16
JOURNAL ARTICLE
Michiel J Bakkum, Erik M Donker, Pietro Spitaleri Timpone, Charlotte A M Hagen, Milan C Richir, Michiel A van Agtmael, Fabrizio De Ponti, Jelle Tichelaar
No abstract text is available yet for this article.
February 7, 2023: European Journal of Clinical Pharmacology
https://read.qxmd.com/read/36749352/could-the-concomitant-use-of-beta-blockers-with-bevacizumab-improve-survival-in-metastatic-colon-cancer
#17
JOURNAL ARTICLE
Mehmet Zahid Kocak, Muhiddin Er, Muzaffer Ugrakli, Engin Hendem, Murat Araz, Melek Karakurt Eryilmaz, Mehmet Artac
AIM: Drug-drug interactions are sometimes neglected in oncology practice. Due to drug pharmacokinetic and pharmacodynamic interactions, clinically increased or decreased drug effects and increased or decreased adverse effects may occur. Considering that the concomitant use of these two drugs that affect vascular endothelial growth factor receptor (VEGFR) may cause pharmacological potentiation or additive interaction, we aimed to evaluate the survival outcomes of concomitant use of bevacizumab and beta blockers in patients with metastatic colorectal cancer (mCRC)...
February 7, 2023: European Journal of Clinical Pharmacology
https://read.qxmd.com/read/36723758/relationship-between-elevated-bilirubin-levels-and-enhanced-warfarin-effects-during-biliary-obstruction
#18
JOURNAL ARTICLE
Takafumi Nakazawa, Shingo Yamazaki, Masashi Uchida, Takaaki Suzuki, Takako Nakamura, Masayuki Ohtsuka, Itsuko Ishii
OBJECTIVES: A marked prolongation of the prothrombin time-international normalized ratio (PT-INR) is frequently observed during biliary obstruction in patients using warfarin. The objective of this study was to identify factors associated with PT-INR prolongation during biliary obstruction in patients using warfarin. METHODS: Among 44 patients using warfarin who had biliary obstruction, we retrospectively investigated warfarin doses and laboratory data before and during biliary obstruction...
February 1, 2023: European Journal of Clinical Pharmacology
https://read.qxmd.com/read/36708395/pharmacogenetics-of-warfarin-dosing-in-chinese-adults-with-nonvalvular-atrial-fibrillation
#19
JOURNAL ARTICLE
Ye Zhu, Jia You, Xiang Gu, Hua Zhu, Jia Liu
BACKGROUND: The guide for the use of genotype-guided warfarin dosing in patients for the treatment of non-valvular atrial fibrillation (AF) is still lacking. AIM: We aimed to evaluate whether genotype-guided warfarin dosing is superior to conventional clinical dosing for the outcomes of interest in Chinese patients. METHOD: Our study consisted of 508 newly recruited and 471 existing Chinese AF patients. Among the total 979 patients, 585 patients received their dose of warfarin determined by a genetic and clinical factor (gene group), while the remaining 394 patients whose dosing was determined empirically in control group...
January 28, 2023: European Journal of Clinical Pharmacology
https://read.qxmd.com/read/36700997/the-effect-of-tetrahydrocannabinol-cannabidiol-oromucosal-spray-on-cognition-a-systematic-review
#20
REVIEW
Ehsan Motaghi, Masoumeh Ghasemi-Pirbaluti, Mohsen Rashidi, Masoud Alasvand, Patricia Di Ciano, Hooman Bozorgi
PURPOSE: Previous studies have shown that tetrahydrocannabinol (THC), the main psychoactive component of cannabis, can impair cognitive abilities. There is also some evidence that cannabidiol (CBD), the most abundant non-intoxicating constituent of cannabis, can attenuate these effects. The purpose of this study was to investigate the effects of THC:CBD oromucosal spray (with equal parts THC and CBD) on cognition compared with control conditions in human studies. METHODS: A systematic literature search was performed on four major bibliographic databases...
January 26, 2023: European Journal of Clinical Pharmacology
journal
journal
25237
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.